Legal & General Group
NEXI

Legal & General Group’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Legal & General Group’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-57
Closed -$2K – 3503
2022
Q2 		$2K Sell
57
-11
-16% -$681 ﹤0.01% 3495
2022
Q1 		$7K Hold
68
– – ﹤0.01% 3475
2021
Q4 		$8K Hold
68
– – ﹤0.01% 3504
2021
Q3 		$26K Buy
68
+43
+172% +$14.4K ﹤0.01% 3189
2021
Q2 		$10K Hold
25
– – ﹤0.01% 3424
2021
Q1 		$12K Buy
+25
New +$13.6K ﹤0.01% 3335

Other funds holding NEXI

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AO
Allen Operations New York $670M AUM 26.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return

Legal & General Group's NEXI Position: Q3 2022 in Review

Legal & General Group sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2022, closing a stake of 57 shares — an estimated $2K sold.

Legal & General Group first reported a position in NEXI in Q1 2021 and held it in 6 quarters. The position peaked at $26K in Q3 2021. 38 funds tracked by Wall St. Rank hold NEXI as of Q3 2022.

  • Legal & General Group reported no remaining NexImmune, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Legal & General Group sold 57 NexImmune, Inc. Common Stock shares in Q3 2022, an estimated $2K.
  • Legal & General Group first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • Legal & General Group's NexImmune, Inc. Common Stock position peaked at $26K in Q3 2021.
  • 38 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2022.

Based on Legal & General Group's 13F filing for Q3 2022, filed 14 Nov 2022.